The store will not work correctly when cookies are disabled.
N,N-Bis(pyridin-2-ylmethyl)-6-(thiophen-3-yl)pyrimidin-4-amine
ID: ALA4467979
PubChem CID: 155532663
Max Phase: Preclinical
Molecular Formula: C20H17N5S
Molecular Weight: 359.46
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: c1ccc(CN(Cc2ccccn2)c2cc(-c3ccsc3)ncn2)nc1
Standard InChI: InChI=1S/C20H17N5S/c1-3-8-21-17(5-1)12-25(13-18-6-2-4-9-22-18)20-11-19(23-15-24-20)16-7-10-26-14-16/h1-11,14-15H,12-13H2
Standard InChI Key: OTHWUACDENGMBZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
26.6068 -8.4319 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.6057 -9.2514 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3137 -9.6604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0234 -9.2510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0206 -8.4283 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.3119 -8.0230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8977 -9.6595 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7317 -9.6584 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.7330 -10.4756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4388 -9.2487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0260 -10.8853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1472 -9.6562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3207 -10.4741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6141 -10.8831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6149 -11.7011 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3283 -12.1085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0319 -11.6971 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.1438 -10.4719 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.8513 -10.8793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5594 -10.4695 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5554 -9.6481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8474 -9.2444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1541 -9.3298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6068 -9.9367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0148 -10.6447 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
25.8143 -10.4753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
2 7 1 0
4 8 1 0
8 9 1 0
8 10 1 0
9 11 1 0
10 12 1 0
11 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 11 1 0
12 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 12 1 0
7 23 1 0
23 24 2 0
24 25 1 0
25 26 1 0
26 7 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 359.46 | Molecular Weight (Monoisotopic): 359.1205 | AlogP: 4.20 | #Rotatable Bonds: 6 |
Polar Surface Area: 54.80 | Molecular Species: NEUTRAL | HBA: 6 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 5.06 | CX LogP: 3.74 | CX LogD: 3.74 |
Aromatic Rings: 4 | Heavy Atoms: 26 | QED Weighted: 0.52 | Np Likeness Score: -1.80 |
References
1. Camacho-Hernandez GA, Stokes C, Duggan BM, Kaczanowska K, Brandao-Araiza S, Doan L, Papke RL, Taylor P.. (2019) Synthesis, Pharmacological Characterization, and Structure-Activity Relationships of Noncanonical Selective Agonists for α7 nAChRs., 62 (22): [PMID:31675224] [10.1021/acs.jmedchem.9b01467] |